Thus, our group observed that activation of AMPK by FLCN loss leads to upregulation of PGC1α and, consequently, elevated mitochondrial biogenesis and oxidative phosphorylation in cancer cells (Yan et al., 2014). The gene discussed is PPARGC1A; the disease is cancer.